Following the recent approval of GLP-1R (glucagon-like peptide-1 receptor) agonist therapies for the pharmacological management of […]
Dia Beta Labs’ CEO, Dr. Ryan Lafferty, took the opportunity to sit down with Barry McCall, […]
In light of World Diabetes Day on 14th November, our CEO, Dr. Ryan Lafferty, was delighted […]
Our very own CEO, Dr. Ryan Lafferty, sat down with Scott Millar from Business Spotlight UK […]